News

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...
Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...
Eli Lilly Chairman and CEO Dave Ricks joins 'Mornings with Maria' to discuss his meeting with President Donald Trump, the ...
Lilly plans to break ground Tuesday afternoon on its $4.5 billion Lilly Medicine Foundry in Lebanon. Lilly Chair and CEO Dave ...
Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...
Trump said he plans to announce pharma tariffs over the next two weeks, his latest on levies that have rattled global ...
U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282 ...
Bluebird urged shareholders to back a take-private deal that could close imminently. Elsewhere, Unity Biotechnology began a strategic review and Mersana announced plans to cut more than half its ...
The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...
Bella Currier and Arianna Terwedo won their match at first doubles over Zoey Owens and Charlotte Corifer with a score of 6-2, ...
Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.
(Reuters) -U.S. President Donald Trump will sign an executive order on Monday to streamline regulations surrounding ...